Brief: Janux Therapeutics Q4 Basic EPS USD -0.25

Janux Therapeutics

08/03/2024 21:01

Mar 08 (Reuters) - Janux Therapeutics Q4 net income USD -11.758 million.
* Q4 operating expenses USD 18.598 million
* Q4 collaboration revenue USD 2.461 million
* Q4 operating income USD -16.137 million